Literature DB >> 16310612

Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients.

Miguel Angel Benitez-Rosario, Antonio Salinas Martin, Manuel Feria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16310612     DOI： 10.1016/j.jpainsymman.2005.10.002

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  8 in total

1.  Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.

Authors:  David Hui; Kelly Kilgore; Minjeong Park; Janet Williams; Diane Liu; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-07-09       Impact factor: 3.612

Review 2.  Dyspnea review for the palliative care professional: treatment goals and therapeutic options.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2012-01       Impact factor: 2.947

3.  Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.

Authors:  David Hui; Kelly Kilgore; Susan Frisbee-Hume; Minjeong Park; Diane Liu; Diwakar D Balachandran; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2017-08-10       Impact factor: 3.612

4.  Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial.

Authors:  David Hui; Angela Xu; Susan Frisbee-Hume; Gary Chisholm; Margarita Morgado; Suresh Reddy; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2013-07-03       Impact factor: 3.612

5.  Fentanyl treatment for end-of-life dyspnoea relief in advanced cancer patients.

Authors:  Miguel Angel Benítez-Rosario; Inmaculada Rosa-González; Enrique González-Dávila; Emilio Sanz
Journal:  Support Care Cancer       Date:  2018-06-18       Impact factor: 3.603

Review 6.  [Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care--overview and case report].

Authors:  Thomas Sitte
Journal:  Wien Med Wochenschr       Date:  2009-12

Review 7.  Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease.

Authors:  Luis Cabezón-Gutiérrez; Parham Khosravi-Shahi; Sara Custodio-Cabello; Francisco Muñiz-González; Maria Del Puerto Cano-Aguirre; Soledad Alonso-Viteri
Journal:  Support Care Cancer       Date:  2016-06-22       Impact factor: 3.603

Review 8.  Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.